Searchable abstracts of presentations at key conferences in endocrinology

ea0035p1065 | Thyroid (non-cancer) | ECE2014

Assessment of thyroid function and volume in hypogonadal patients

Arpaci Dilek , Cuhaci Neslihan , Saglam Fatma , Ozdemir Didem , Ersoy Reyhan , Cakir Bekir

Background: Hypogonadism is related to additional endocrine abnormalities. Thyroid abnormalities may be common in hypogonadism patients, although this association is not clear.Objective: In this study, we examined the incidence of thyroid disorders in hypogonadisms.Methods: A case–control study of 68 hypogonadal patients and 74 age-matched healthy controls from the general population was conducted. Thyroid function, thyroid vo...

ea0070aep138 | Bone and Calcium | ECE2020

A new and valuable predictor for the diagnosis of primary hyperparathyroidism: Ca/P Ratio

Bestepe Nagihan , cuhaci Neslihan , Polat Burcak , Ogmen Berna , Ersoy Reyhan , Cakir Bekir

Introduction: Primary hyperparathyroidism (PHPT) is a common endocrine disorder that is characterized by hypercalcemia and elevated or normal levels of parathyroid hormone (PTH). Most PHPT cases are incidentally discovered when routine laboratory analysis reveals hypercalcemia. PHPT should be considered in any person with elevated serum calcium (Ca) levels and no clear evidence of malignancy. Serum phosphorus (P) is low due to the phosphaturic effects of PTH and mostly in the ...

ea0070aep188 | Bone and Calcium | ECE2020

Hypercalcemia and primary hyperparathyroidism case progressing during the treatment of dapagliflozin

Akhanli Pinar , Hepsen Sema , Uçan Bekir , Saylam Güleser , Çakal Erman

Introduction: Hypercalcemia associated with the use of a SGLT-2 inhibitor is a very rare adverse effect. Herein we reported a case of apparent primary hyperparathyroidism that occurred while applying the treatment of dapagliflozin in a patient with asymptomatic primary hyperparathyroidism.Case report: A 49-year-old male patient with 5 years of diabetes mellitus history admitted for his routine control and Hba1c level was observed 7.9%. Dapagliflozin (1 &...

ea0070aep321 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Severe insulin resistance with cirrhosis: A case report

Durmaz Himmet , Evranos Ogmen Berna , Ahmadova Konul , Kucukcongar Yavas Aynur , Keskin Caglar , Dirikoc Ahmet , Cakir Bekir

Background: Alstrom syndrome is a rare autosomal recessive genetic disorder characterised by vision loss, hearing loss, childhood obesity, insulin resistance and hyperinsulinemia, type 2 diabetes, hypertriglyceridemia, cardiomyopathy, and progressive pulmonary, hepatic, and renal dysfunction. Hyperinsulinemia develops early, and pancreatic islets show beta-cell proliferation, thus suggesting that both insulin resistance and increased insulin secretion might contribute to gluco...

ea0070aep770 | Pituitary and Neuroendocrinology | ECE2020

Massive pulmonary embolism in a newly diagnosed acromegaly patient

Hepsen Sema , Ucan Bekir , Akhanli Pinar , Ozturk Unsal Ilknur , Cakal Erman

Introduction: Acromegaly is caused by growth hormone (GH) and insulin-like growth factor (IGF-1) excess and leads to various comorbidities. However, the association between acromegaly and thromboembolic diseases is unclear. Herein, we present a newly diagnosed acromegaly patient with massive pulmonary embolism.Case report: A 61-year-old female was hospitalized with acromegaly pre-diagnosis. She complained about extensive arthralgia and snoring. She had h...

ea0070ep100 | Bone and Calcium | ECE2020

Nonmedullary hypercalcitoninemia in a hypocalcemic patient: Shoud we look at serum calcitonin level in the differantial diagnosis of hypocalcemia?

Durmaz Himmet , Aydin Cevdet , Ahmadova Konul , Dirikoc Ahmet , Ersoy Reyhan , Cakir Bekir

Background: Although high levels of calcitonin suggest neoplastic proliferations such as medullary thyroid carcinoma, C cell hyperplasia and some neuroendocrine tumors, systemic diseases and drugs may also elevate calcitonin. Although calcitonin is not as effective as PTH, it has got a role in calcium hemoastasis. Supraphysiological calcitonin level can lead to hypocalcemia.Case presentation: A 57-year-old male patient was diagnosed with epilepsy with co...

ea0032p245 | Clinical case reports – Pituitary/Adrenal | ECE2013

Ectopic acth dependent Cushing syndrome diagnosed with octreotide scan

Onal Eda Demir , Oguz Oguzhan , Polat Burcak , Kandemir Zuhal , Karaoglanoglu Nurettin , Ersoy Reyhan , Cakir Bekir

Ectopic secretion of corticotropin(ACTH) by nonpituitary tumors accounts for 10–15% of ACTH dependent Cushing’s syndrome (CS). Generally it is difficult to localize the ACTH secreting tumor by conventional imaging methods because these tumors are often small in size. Here we present a case of ectopic ACTH syndrome diagnosed with octreotide scan.Case: A 26-year-old male patient presented with moon face, purplish striae, supraclavicular fat pads ...

ea0032p265 | Clinical case reports – Pituitary/Adrenal | ECE2013

Differential diagnosis of an incidental pituitary lesion detected with PET-CT in a patient with a known history of metastatic maxillary sinus tumor

Baser Husniye , Cuhaci Neslihan , Ozdemir Elif , Saglam Fatma , Ersoy Reyhan , Cakir Bekir

Introduction: Metastatic pituitary tumors are seen rarely and it is hard to differentiate them from the benign lesions of the gland. We have reported a case, with a known maxillary sinus tumor, detected to have a pituitary lesion coincidentally on PET-CT.Case: 45 years old male patient with a known history of relapsed maxillary sinus tumor has been referred to our clinics because of the pituitary lesion detected to have increased FDG involvement on PET-C...

ea0032p279 | Clinical case reports - Thyroid / Others | ECE2013

Giant cell granuloma as initial presentation of primary hyperparathyroidism: a case report

Polat Sefika Burcak , Taskaldiran Isilay , Evranos Berna , Kilicaslan Aydan , Kaya Elif , Ersoy Reyhan , Cakir Bekir

Giant cell granuloma is a skeletal manifestation seen now rarely in hyperparathyroidism due to early recognition of the disease. Lesions usually occur in the areas of intense bone resorption. They can affect mandible, maxilla, clavicle, ribs and pelvic bones. Most of the patients who have primary hyperparathyroidism are asymptomatic and are discovered incidentally during laboratory examinations. Here, we represent a female patient who was referred to endocrinology clinics beca...

ea0032p297 | Clinical case reports - Thyroid / Others | ECE2013

Primary hyperparathyroidism associated with atrial septal defect, interatrial septal aneurisym and skeletal anomaly: a case report

Cuhaci Fatma Neslihan , Polat Sefika Burcak , Evranos Berna , Keles Telat , Ersoy Reyhan , Cakir Bekir

The classic clinic manifestation of primary hyperparathyroidism (PHPT) is osteitis fibrosa cystica, a severe skeletal disease characterized by brown tumors, bone cysts and deformities, due to extremely elevated bone resorption elicited by continuously high parathyroid hormone (PTH) levels. In cardiovascular system there may be shortened QT interval, deposition of calcium in heart valves, coronary arteries, and myocardial fibers. Here, we report a case with PHPT, who have anore...